Remote care for sleep apnea may rival In-Person visits for blood pressure control

NCT ID NCT06064630

Completed Disease control Sponsor: Peking University People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether managing sleep apnea remotely with a breathing device (APAP) can lower blood pressure as well as traditional in-person care. Researchers enrolled 344 adults with suspected sleep apnea in Beijing. Participants were randomly assigned to either telemedicine-based or outpatient management. The main goal was to see if 24-hour blood pressure improved similarly in both groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Automatic continuous positive airway pressure (APAP) device
What this could lead to: If successful, this could show that remote care for sleep apnea is as effective as in-person visits for lowering blood pressure, making treatment more accessible.
What could go wrong: This is a completed single-center trial, so results may not apply broadly. The study compares management methods, not a new treatment, so the impact is limited to care delivery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP APNEA, OBSTRUCTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SLEEP APNEA, OBSTRUCTIVE

Contacts and locations

Locations

Peking University People's Hospital

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.